CD14 expression and soluble CD14 after segmental allergen provocation in atopic asthma

European Respiratory Journal

Volumn 11, Issue 2, 1998, Pages 317-323

  Virchow Jr , J C ^a   Julius, P ^a   Matthys, H ^a   Kroegel, C ^b   Luttmann, W ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Allergen provocation; Asthma; CD14; Macrophages; Soluble CD14

Indexed keywords

CD14 ANTIGEN; MEMBRANE ANTIGEN;

ADULT; ALLERGIC ASTHMA; ARTICLE; ASTHMA; CELL ACTIVATION; CELL DIFFERENTIATION; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATORY CELL; LIQUID; LUNG LAVAGE; MACROPHAGE; MALE; PNEUMONIA; PRIORITY JOURNAL; PROVOCATION; PROVOCATION TEST;

ADULT; ALLERGENS; ANTIGENS, CD14; ASTHMA; BLOOD CELL COUNT; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; FEMALE; GRANULOCYTES; HUMANS; HYPERSENSITIVITY; IMMUNOLOGIC TECHNIQUES; MACROPHAGES; MALE; SOLUBILITY;

EID: 0031951315     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.11020317     Document Type: Article

References (37)

1. Goyert SM, Ferrero E, Rettig WJ, Yenamandra AK, Obata F, Le Beau MM. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 1988; 239: 497-500.
2. Ziegler-Heitbrock HW, Ulevitch RJ. CD14: cell surface receptor and differentiation marker. Immunol Today 1993; 14: 121-125.
3. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD 14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
4. Dentener MA, Bazil V, Von Asmuth FJ, Ceska M, Buurman WA. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol 1993; 150: 2885-2891.
5. Lauener RP, Goyert SM, Geha RS, Vercelli D. Interleukin 4 down-regulates the expression of CD14 in normal human monocytes. Eur J Immunol 1990; 20: 2375-2381.
6. Ruppert J, Friedrichs D, Xu H, Peters JH. IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency. Immunobiology 1991; 182: 449-464.
7. Firestein GS, Zvaifler NJ. Down regulation of human monocyte differentiation antigens by interferon gamma. Cell Immunol 1987; 104: 343-354.
8. Ishizuka T, Hirata I, Adachi M, et al. Effects of interferon-gamma on cell differentiation and cytokine production of a human monoblast cell line, U937. Inflammation 1995; 19: 627-636.
9. Striz I, Zheng L, Wang YM, Pokorna H, Bauer PC, Costabel U. Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14. Am J Respir Crit Care Med 1995; 151: 544-547.
10. Landmann R, Fisscher AK, Obrecht JP. Interferon-gamma and interleukin-4 down-regulate soluble CD14 release in human monocytes and macrophages. J Leukoc Biol 1992; 52: 323-330.
11. Bufler P, Stiegler G, Schuchmann M, et al. Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants. Eur J Immunol 1995; 25: 604-610.
12. Schutt C, Schilling T, Grunwald U, Schonfeld W, Kruger C. Endotoxin-neutralizing capacity of soluble CD14. Res Immunol 1992; 143: 71-78.
13. Cosentino G, Soprana E, Thienes CP, Siccardi AG, Viale G, Vercelli D. IL-13 down-regulates CD14 expression and TNF-alpha secretion in normal human monocytes. J Immunol 1995; 155: 3145-3151.
14. Labeta MO, Durieux JJ, Fernandez N, Herrmann R, Ferrara P. Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD 14. Eur J Immunol 1993; 23: 2144-2151.
15. Hoheisel G, Zheng L, Teschler H, Striz I, Costabel U. Increased soluble CD14 levels in BAL fluid in pulmonary tuberculosis. Chest 1995; 108: 1614-1616.
16. Martin TR, Rubenfeld G, Steinberg KP, et al. Endotoxin, endotoxin-binding protein, and soluble CD14 are present in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Chest 1994; 105: 55S-56S.
17. Pforte A, Schiessler A, Gais P, et al. Increased expression of the monocyte differentiation antigen CD14 in extrinsic allergic alveolitis. Monaldi Arch Chest Dis 1993; 48: 607-612.
18. Pforte A, Schiessler A, Gais P, et al. Expression of CD14 correlates with lung function impairment in pulmonary sarcoidosis. Chest 1994; 105: 349-354.
19. Dubin W, Martin TR, Swoveland P, et al. Bronchoalveolar lavage, segmental allergen challenge, macrophage, interleukin-6, endothelial cell, asthma and endotoxin-lipopolysaccharide binding protein and soluble CD14 in bronchoalveolar compartment. Am J Physiol Lung Cell Mol Physiol 1996; 14: L736-L744.
20. Virchow JC Jr, Walker C, Hafner D, et al. T-cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med 1995; 151: 960-968.
21. Chanez P, Bousquet J, Couret I, et al. Increased numbers of hypodense alveolar macrophages in patients with bronchial asthma. Am Rev Respir Dis 1991; 144: 923-930.
22. Anonymous. International consensus report on diagnosis and treatment of asthma. National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA. Eur Respir J 1992; 5: 601-641.
23. Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7: 235-243.
24. Ruhle KH, Matthys H. Kritische Auswahl von Sollwerten für ein Computerprogramm zur Routinlungenfunktionsdiagnostik. Pneumonologie 1976; 153: 223-233.
25. Warren HS, Glennon ML, Wainwright N, et al. Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor. Infect Immun 1992; 60: 2506-2513.
26. Luttmann W, Herzog V, Virchow JC Jr, Matthys H, Thierauch KH, Kroegel C. Prostacyclin modulates granulocyte/macrophage colony-stimulating factor release by human blood mononuclear cells. Pulmonary Pharmacology 1996; 9: 43-48.
27. Zhang DE, Hetherington CJ, Tan S, et al. Sp1 is a critical factor for the monocytic specific expression of human CD14. J Biol Chem 1994; 269: 11425-11434.
28. Postma DS, Bleecker ER, Amelung PJ, et al. Genetic susceptibility to asthma, bronchial hyperresponsiveness co-inherited with a major gene for atopy. N Engl J Med 1995; 333: 894-900.
29. Michel O, Duchateau J, Sergysels R. Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. J Appl Physiol 1989; 66: 1059-1064.
30. Michel O, Ginanni R, Duchateau J, Vertongen F, Le Bon B, Sergysels R. Domestic endotoxin exposure and clinical severity of asthma. Clin Exp Allergy 1991; 21: 441-448.
31. Kroegel C, Julius P, Matthys H, Virchow JC Jr, Luttmann W. Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: relationship to interleukin-4 and eosinophil counts. Ear Respir J 1996; 9: 899-904.
32. Salomonsson P, Gronneberg R, Gilljam H, et al. Bronchial exudation of bulk plasma at allergen challenge in allergic asthma. Am Rev Respir Dis 1992; 146: 1535-1542.
33. Fick RB Jr, Metzger WJ, Richerson HB, et al. Increased bronchovascular permeability after allergen exposure in sensitive asthmatics. J Appl Physiol 1987; 63: 1147-1155.
34. Maciejewski JP, Young NS, Yu M, Anderson SM, Sloand EM. Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria. Thrombosis Research 1996; 83: 433-447.
35. Hunt LW, Gleich GJ, Ohnishi T, et al. Endotoxin contamination causes neutrophilia following pulmonary allergen challenge. Am J Respir Crit Care Med 1994; 149: 1471-1475.
36. Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-304.
37. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1481-1486.